Rare disease cures accelerator-data and analytics platform milestones highlighted

(Critical Path Institute (C-Path)) C-Path and NORD ® hosted the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP) 2020 Virtual Workshop on Monday, October 19. The platform, funded by a cooperative agreement through the U.S. Food and Drug Administration (FDA), serves as a centralized and standardized infrastructure to support data sharing and data analysis to aid in the understanding of rare diseases.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news